Stock Options (Tables)

3 Months Ended

Mar. 31, 2026

Stock-based compensation expense recognized for options was as follows:


	For the Three Months Ended March 31,
		2026		2025
Research and development		$	306	$	570
General and administrative		5,843		29,831
Total		$	6,149	$	30,402

The following table summarizes information about options outstanding and exercisable at March 31, 2026:


		Options Outstanding				Options Exercisable
Exercise Price		Number of Options at March 31, 2026	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number of Options Exercisable at March 31, 2026	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price
$	0.29	134,084	9.7 years	$	0.29	41,818	9.7 years	$	0.29


$	340.20	3,999	3.6 years	$	340.20	3,999	3.6 years	$	340.20
$	413.59	200	7.5 years	$	413.59	130	7.5 years	$	413.59
		138,283				45,947

Total stock option activity for the three months ended March 31, 2026, is summarized as follows:


	Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2025	139,922	$	12.10	3.7 years	—
Granted	—	—		—	—
Exercised	—	—		—	—
Forfeited	(1,639)	—		—	—
Outstanding at March 31, 2026	138,283	$	12.10	9.7 years	—
Vested and Exercisable at March 31, 2026	45,947	31.04		9.2 years	—